Medical News

RSS

Last patient visit complete in VIA Pharmaceuticals' Phase 2 FDG-PET trial

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that it has completed the last patient visit in its Phase 2 FDG-PET clinical trial of VIA-2291.

3 Dec 2009

Senators prepare to debate abortion treatment in Senate bill

The Associated Press: "Senators debating health care legislation are headed for a clash over abortion, the issue that threatened to derail the bill in the House. Anticipating the showdown, hundreds of abortion rights supporters gathered on Capitol Hill Wednesday to call on senators to keep new abortion restrictions out of the health care bill.

3 Dec 2009

Will 'Cadillac tax' push employers to trim health insurance costs

Kaiser Health News staff writer Julie Appleby examines the potential reach of the Cadillac tax.

3 Dec 2009

Shire voluntarily recalls specific lots of its Daytrana ADHD patches

Shire plc, the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and caregivers could have difficulty removing the liners.

3 Dec 2009

Today's opinions and editorials

Defenders of the status quo in health care would happily let the drive for reform bog down amid a debate over President Obama's new war strategy. Democrats can't let this happen (12/3).

3 Dec 2009

Senate leaders say health bill amendment votes to start today

The Wall Street Journal reports that "after three days of debates without a vote on a single amendment ... Senate Minority Whip Richard Durbin, (D., Ill.) announced Wednesday evening that" Republicans and Democrats had "come to agreement" on how to proceed. The first two votes will occur today "on amendments aimed at requiring health plans to cover preventive services for women's health.

3 Dec 2009

NIH approves new stem cell lines for research

The National Institutes of Health announced approval of embryonic stem cell lines for federally funded research. The Washington Post reports the decision is "opening the way for millions of taxpayer dollars to be used to conduct research that was put off-limits by President George W. Bush.

3 Dec 2009

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide.

3 Dec 2009

Medicare cuts in Senate health bill get support from seniors' groups

Bloomberg: Senate Democratic leaders, who are battling Republican attempts to "block Medicare spending cuts, face an even bigger headache: overcoming concern among members of their own party about the program's future funding."

3 Dec 2009

KHN column: Debating cost control

In his latest Kaiser Health News column, James Capretta explores perspectives related to cost control in health reform.

3 Dec 2009

GOP playbook highlights Senate procedural tactics

A memo circulated by Sen. Judd Gregg, R-N.H., spells out the arsenal of parliamentary maneuvers available to Republicans as they seek to stall the Senate's health debate, The New York Times reports on its Prescriptions blog. Gregg has a reputation as one of the GOP's "foremost experts on legislative war games."

3 Dec 2009

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

iCo Therapeutics Inc. is pleased to announce that an overview of iCo-007, entitled "iCo-007 a VEGF "+" Agent for the Potential Treatment of Diabetic Macular Edema and Diabetic Retinopathy" will be presented at the 8th International Symposium on Ocular Pharmacology and Therapeutics ("ISOPT"), a major international ocular conference.

3 Dec 2009

Doctors' groups break ranks to oppose Senate health overhaul

The California Medical Association - which represents more than 35,000 doctors - will announce its opposition to the Senate version of the health overhaul bill later this week, the Los Angeles Times reports. The group's leaders voted to oppose the bill last week, joining several other states, including Florida and Texas.

3 Dec 2009

At House hearing, panel seeks to clarify advice on mammograms

Members of the U.S. Preventive Services Task Force testified at a hearing Wednesday before the the House Energy and Commerce subcommittee on health.

3 Dec 2009

Initial positive data from Amira Pharmaceuticals' Phase 1 clinical study of AM461 DP2 antagonist

Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM461, the Company's second oral selective antagonist of the DP2 (also known as CRTH2) receptor.

3 Dec 2009

Reid still seeks common ground on public option

"The public option has gone through several stages of evolution this year, but it could soon face extinction unless one of the new versions picks up political momentum," The Hill reports.

3 Dec 2009

States weigh health cuts; Mass. considers student health 'revision'

News outlets report on budget squeezes in Oklahoma and Florida and a proposed overhaul of student health insurance in Massachusetts.

3 Dec 2009

Fear of swine flu impacts lifestyle

One of the lasting legacies of 2009 and looming challenges of 2010 is the H1N1 virus. Fears about contracting H1N1 (commonly known as the swine flu) have consumed many Americans for most of the year, so EarnMyDegree.com (http://www.earnmydegree.com), a web resource of EducationDynamics, which connects prospective students with online classes, commissioned a new study about whether flu-related worries have caused people to change their habits.

3 Dec 2009

Enzon Pharmaceuticals announces share repurchase program

Enzon Pharmaceuticals, Inc. announced today that its Board of Directors has authorized the repurchase of up to $50 million of its outstanding shares of common stock in order to return value to its shareholders.

3 Dec 2009

Don't stop dieting during the holiday season

As Americans gear up for the holiday season this month, Dr. Sasson Moulavi, a Board Certified Bariatric Physician, cautions that overweight and obese patients not give in to temptation and forget their dieting. Rather, Dr. Sass, founder of the Smart for Life(R) Cookie Diet, recommends alternative behavior for a positive outcome when it is time to ring in the New Year.

3 Dec 2009